Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban in Acute Ischemic Stroke Beyond the Time Window Guided by HR-MRI
NCT07379190Phase 3Recruiting
- Sponsor
- Shandong Second Medical University
- Start
- Jun 2026
- Primary completion
- Feb 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirofiban in ischemic stroke, sponsored by Shandong Second Medical University. Started Jun 2026; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07379190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07379190.